Article
Blood<i>N</i>-glycomic signature of fibrosis in MASLD shows low levels of global α2,3-sialylation
2024-09-22
Abstract excerpt
<h4>Background & Aims</h4> Alterations in the glycosylation of blood proteins affect protein functionality and have been linked to various diseases. Metabolic dysfunction- associated steatotic liver disease (MASLD) is a silent disease, of which progression to advanced disease stages including metabolic dysfunction-associated steatohepatitis (MASH), fibrosis and cirrhosis often goes unnoticed. As current non- invas...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a01c465e-4896-50ec-89f0-e3247ba8130d
- DOI
- 10.1101/2024.09.19.24313949
